RecruitingNCT02527486

Seoul National University Airway Registry

Airway Registry for Chronic Airway Diseases


Sponsor

Seoul National University Hospital

Enrollment

800 participants

Start Date

Sep 1, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

This is a multicenter, prospective observational cohort study, in which patients with chronic airway diseases including chronic obstructive pulmonary disease(COPD), asthma, asthma-COPD overlap syndrome (ACOS) will be recruited.


Eligibility

Min Age: 20 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This is a patient registry (a database that collects health information over time) at Seoul National University for people with chronic airway diseases — including COPD (a lung disease typically caused by smoking), asthma, or a combination of both — to better understand how these conditions progress. **You may be eligible if...** - You have COPD: confirmed by a breathing test showing reduced airflow after using a bronchodilator, plus ongoing respiratory symptoms - You have asthma: you have never smoked heavily (less than 5 pack-years), you have recurring asthma symptoms like wheezing or chest tightness, and you have a positive test for airway reactivity - You have features of both COPD and asthma (sometimes called ACOS) **You may NOT be eligible if...** - The criteria above do not apply to your condition Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Seoul National University Hospital

Seoul, South Korea

Seoul Metropolitan Government-Seoul National University Boramae Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02527486


Related Trials